|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1212 NEW YORK AVENUE, NW |
Address2 | SUITE 800 |
City | WASHINGTON |
State | DC |
Zip Code | 20005-6105 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 1262-12
|
||||||||
|
6. House ID# 305260000
|
TYPE OF REPORT | 8. Year | 2012 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Annetha Hall, Director Operations and Special Programs |
Date | 04/20/2012 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
P.L. 111-375 National Alzheimers Project Act, All Sections
S. 738/H.R. 1386 Health Outcomes, Planning and Education for Alzheimer's Act, All sections
S. 525 Positive Aging Act of 2011
S. 1263 National Silver Alert Act of 2011
P.L. 111-148/111-152 Patient Protection and Affordable Care Act - All Sections related to care coordination, transitional care, long term care services and supports access to affordable insurance, establishment of a national voluntary disability insurance program, provisions related to individuals with Alzheimer's disease and caregivers and provisions related to research including the Cures Acceleration Network.
Reauthorization of the Older American's Act
H.R. 2798 Alzheimer's Caregiver Support Act, All sections
H.R. 2800 Missing Alzheimer's Disease Patient Alert Program Reauthorization of 2011, All sections
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS), Veterans Affairs - Dept of (VA), Food & Drug Administration (FDA), Natl Institutes of Health (NIH), Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mary |
Richards |
|
|
|
Lauren |
Bates |
|
|
|
Jennifer |
Sheridan |
|
|
|
Rachel |
Conant |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Fiscal Year 2012 Labor, Health & Human Services, Education and Related Agencies Appropriations Bill, All sections related to the National Institutes of Health, Alzheimer's Disease, and the Cures Acceleration Network.
Fiscal Year 2012 Agriculture Appropriations Bill, All sections related to the Food and Drug Administration.
Fiscal Year 2012 Defense Appropriations Bill, All sections related to health research.
Fiscal Year 2013 Labor, Health & Human Services, Education and Related Agencies Appropriations Bill, All sections related to the National Institutes of Health, Alzheimer's Disease, and the Cures Acceleration Network.
Fiscal Year 2013 Agriculture Appropriations Bill, All sections related to the Food and Drug Administration.
Fiscal Year 2013 Defense Appropriations Bill, All sections related to health research.
Fiscal Year 2013 Commerce, Justice, and Science Appropriations Bill, all sections related to Alzheimer's.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Food & Drug Administration (FDA), Natl Institutes of Health (NIH), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mary |
Richards |
|
|
|
Lauren |
Bates |
|
|
|
Jennifer |
Sheridan |
|
|
|
Rachel |
Conant |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
H.R. 1897 Alzheimer's Breakthrough Act of 2011, All Sections
H.R. 610 Making Investments Now for Dementia Act of 2011, All Sections
H.R. 3497 Modernizing our Drug & Diagnostics Evaluation and Regulator Network Cures Act", All Sections
S. 2113 Transforming the Regulatory Environment to Accelerate Access to Treatments Act, All Sections
H.Res 351/S.Res 176 Supporting a Semipostal Stamp to Support Medical Research Relating to Alzheimer's Disease, All Sections
S.2069/H.R.3891 Spending Reductions through Innovations in Therapies Agenda Act of 2012, All Sections.
Reauthorization of the Prescription Drug User Fee Act, All Sections
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Food & Drug Administration (FDA), Natl Institutes of Health (NIH)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mary |
Richards |
|
|
|
Lauren |
Bates |
|
|
|
Jennifer |
Sheridan |
|
|
|
Rachel |
Conant |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |